|
Volumn 164, Issue 8 II, 2001, Pages
|
Anti-immunoglobulin E (omalizumab) therapy in allergic asthma
|
Author keywords
Anti IgE; Asthma; IgE; Omalizumab
|
Indexed keywords
BECLOMETASONE DIPROPIONATE;
BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT;
CORTICOSTEROID;
IMMUNOGLOBULIN E ANTIBODY;
IMMUNOGLOBULIN G;
MONOCLONAL ANTIBODY;
OMALIZUMAB;
SALBUTAMOL;
UNCLASSIFIED DRUG;
ALLERGIC ASTHMA;
CLINICAL TRIAL;
DISEASE EXACERBATION;
DRUG EFFECT;
DRUG EFFICACY;
DRUG SAFETY;
DRUG TOLERABILITY;
DRUG USE;
HUMAN;
PRIORITY JOURNAL;
QUALITY OF LIFE;
REVIEW;
SYMPTOM;
TREATMENT FAILURE;
|
EID: 0035888741
PISSN: 1073449X
EISSN: None
Source Type: Journal
DOI: 10.1164/ajrccm.164.supplement_1.2103026 Document Type: Review |
Times cited : (77)
|
References (13)
|